Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma
- 11 April 2020
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 85 (2), 345-352
- https://doi.org/10.1016/j.jaad.2020.04.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Blood Pressure Monitoring During the Induction and Maintenance Period of Propranolol Therapy for Complicated Infantile Hemangiomas: A Prospective Study of 109 InfantsPediatric Dermatology, 2015
- Experience with Holter monitoring during propranolol therapy for infantile hemangiomasJournal of the American Academy of Dermatology, 2015
- Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas?Journal of the American Academy of Dermatology, 2015
- A Randomized, Controlled Trial of Oral Propranolol in Infantile HemangiomaThe New England Journal of Medicine, 2015
- Twenty‐Four‐Hour Hospitalization for Patients Initiating Systemic Propranolol Therapy for Infantile Hemangiomas—Is It Indicated?Pediatric Dermatology, 2013
- Propranolol and Infantile Hemangiomas Four Years Later: A Systematic ReviewPediatric Dermatology, 2013
- Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus ConferencePEDIATRICS, 2013
- Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studiesThe Lancet, 2011
- Hyperkalemia Complicating Propranolol Treatment of an Infantile HemangiomaPEDIATRICS, 2010
- Propranolol for Severe Hemangiomas of InfancyThe New England Journal of Medicine, 2008